Ligamys
DeviceAll patients are treated with Ligamys within 21 days after injury. The Ligamys implant has to be used in accordance with the instructions for use.
NCT Number: NCT02203214
The purpose of this study is to evaluate the safety and effectiveness of the Ligamys technique for the treatment of acute ruptures of the anterior cruciate ligament in a multicenter routine clinical setting. To conduct a long-term follow-up of the case series as a post-market product surveillance endeavor.
Looking for future studies?
Notify Me18 year–50 year
All sexes
Observational
UZ Gent, Ghent, Belgium
The Ligamys method was successfully applied in an animal study including eleven white alpine sheep. Healing of the torn ACL and a stable joint without signs of intra-articular damages or osteoarthritis three months postoperative were observed (Kohl KSSTA 2013). In a first clinical study with ten patients, the Ligamys surgical technique resulted in stable clinical and radiological healing of the torn ACL in nine patients with one re-rupture after four months. Nine patients obtained normal knee scores, reported excellent patient satisfaction, and could return to their previous levels of sporting activity (Kohl Swiss Med Wkly 2011).
The purpose of this study is to evaluate the safety and effectiveness of the Ligamys technique for the treatment of acute ruptures of the anterior cruciate ligament in a multicenter routine clinical setting. To conduct a long-term follow-up of the case series as a post-market product surveillance endeavor.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
All patients are treated with Ligamys within 21 days after injury. The Ligamys implant has to be used in accordance with the instructions for use.
Time frame: 12 months follow-up
Knee stability: Lachman test Knee function: Lysholm score, IKDC score Safety: ACL re-ruptures or instabilities leading to an implant removal
Time frame: 10 years follow-up
Mathys Ltd Bettlach
Industry
Acronym: Ligamys
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06769711
Anterior Cruciate Ligament Injuries, Anterior Cruciate Ligament Rupture
Trabzon, Turkey (Türkiye)
View Trial DetailsNCT07555782
Anterior Cruciate Ligament Injuries, Anterior Cruciate Ligament Rupture
Ataşehir, Istanbul, Turkey (Türkiye)
View Trial DetailsNCT07564336
Anterior Cruciate Ligament Graft Failure, Anterior Cruciate Ligament Injuries
Graz, Styria, Austria
View Trial DetailsNCT05440890
Anterior Cruciate Ligament Injuries, Anterior Cruciate Ligament Rupture
Málaga, Spain
View Trial Details